| Ticker Symbol | Name | Issuer | Category | Market Cap | Yield | Expense Ratio | Last Price | 30 Day Change % | Description |
|---|---|---|---|---|---|---|---|---|---|
| AGNG | Global X Aging Population ETF | Global X | Passive Equity | $53,819,351 | 0.64% | 0.50% | $26.99 | 5.60% | Seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age. |
| ARKG | ARK Genomic Revolution ETF | ARK | Active Equity | $1,843,405,000 | 0.00% | 0.75% | $13.40 | 19.32% | The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors. |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | Virtus Investment Partners | Passive Equity | $9,088,551 | 0.00% | 0.79% | $21.52 | 9.97% | The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. |
| BBH | VanEck Biotech ETF | VanEck | Passive Equity | $445,047,686 | 0.49% | 0.35% | $161.70 | 3.43% | Seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR). |
| BBP | Virtus LifeSci Biotech Products ETF | Virtus Investment Partners | Passive Equity | $15,660,209 | 0.00% | 0.79% | $52.84 | 9.57% | Seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. |
| BIB | ProShares Ultra Nasdaq Biotechnology | ProShares | Passive Equity | $76,716,750 | 0.04% | 0.95% | $51.69 | 6.08% | Seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index. |
| BIS | ProShares UltraShort Nasdaq Biotechnology | ProShares | Passive Equity | $4,453,431 | 0.62% | 0.95% | $20.91 | -6.47% | Seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index. |
| BMED | BlackRock Future Health ETF | Blackrock | Active Equity | $3,619,504 | 0.00% | 0.85% | $23.66 | 6.86% | Seeks to maximize total return by investing in innovative and emerging companies in the healthcare sector. |
| BTEC | Principal Healthcare Innovators ETF | Principal | Active Equity | $42,291,931 | 0.00% | 0.42% | $32.27 | 13.16% | Seeks to tap into the increasing demand for healthcare solutions as demographic trends have driven healthcare spending to more than double in the last 20 years.1 |
| CHB | Global X China Biotech Innovati | Global X | Passive Equity | $2,288,250 | 0.44% | 0.67% | $7.14 | 6.34% | Seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. |
| CHNA | Loncar China BioPharma ETF | Exchange Traded Concepts | Passive Equity | $0 | 0.00% | 0.79% | $14.84 | 0.00% | The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. |
| CNBS | Amplify Seymour Cannabis ETF | Amplify Investments | Active Equity | $27,283,500 | 0.00% | 0.75% | $3.73 | 14.32% | CNBS is an ETF investing in the fast-developing global cannabis industry. The Fund is managed by Tim Seymour, a recognized voice and experienced investor in the cannabis space. |
| CURE | Direxion Daily Healthcare Bull 3x Shares | Direxion | Passive Equity | $174,990,547 | 1.75% | 0.97% | $98.94 | 10.78% | Seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index |
| EDOC | Global X Telemedicine & Digital | Global X | Passive Equity | $66,337,500 | 0.00% | 0.68% | $10.06 | 10.77% | Seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index. |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | First Trust | Passive Equity | $1,183,627,787 | 0.00% | 0.55% | $153.29 | 5.54% | Exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. |
| FHLC | Fidelity MSCI Health Care Index ETF | Fidelity | Fixed Income | $2,927,610,000 | 1.40% | 0.08% | $63.01 | 4.56% | Seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index. Investing at least 80% of assets in securities included in the fund's underlying index. |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | First Trust | Fixed Income | $20,096,050 | 1.64% | 0.60% | $26.92 | 2.78% | Seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index™. |
| FXH | First Trust Health Care AlphaDEX Fund | First Trust | Passive Equity | $1,238,123,195 | 0.24% | 0.61% | $102.56 | 5.77% | Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant Health Care Index. |
| GERM | ETFMG Treatments Testing and Advancements ETF | ETFMG | Fixed Income | $12,502,000 | 1.22% | 0.68% | $19.29 | 7.56% | Designed to give exposure to the biotech companies engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies. |
| GNOM | Global X Genomics & Biotechnology ETF | Global X | Equity | $95,658,000 | 0.00% | 0.50% | $11.05 | 15.93% | Seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | Exchange Traded Concepts | Passive Equity | $63,014,268 | 0.00% | 0.68% | $27.73 | 10.73% | Seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index. |
| IBB | iShares Biotechnology | Blackrock | Passive Equity | $6,608,140,000 | 0.26% | 0.44% | $127.58 | 4.95% | The iShares Biotechnology ETF Seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. |
| IBBQ | Invesco Nasdaq Biotechnology ETF | Invesco | Passive Equity | $16,522,800 | 0.84% | 0.19% | $20.49 | 3.53% | Based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. |
| IBRN | iShares Neuroscience and Healthcare ETF | Blackrock | Passive Equity | $4,395,980 | 0.04% | 0.47% | $22.85 | 8.80% | Seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience. |
| IDNA | iShares Genomics Immunology and Healthcare ETF | Blackrock | Passive Equity | $121,325,000 | 0.34% | 0.47% | $21.92 | 13.38% | Seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering. |
| IHE | iShares U.S. Pharmaceuticals ETF | Blackrock | Passive Equity | $575,491,150 | 1.95% | 0.39% | $189.89 | 3.86% | Seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. |
| IHF | iShares U.S. Healthcare Providers ETF | Blackrock | Passive Equity | $912,657,785 | 0.88% | 0.39% | $250.43 | 3.47% | Seeks to track the investment results of an index composed of U.S. equities in the healthcare providers sector. |
| IHI | iShares U.S. Medical Devices | Blackrock | Passive Equity | $5,092,762,500 | 0.52% | 0.39% | $51.74 | 8.65% | Seeks to track the investment results of an index composed of U.S. equities in the medical devices sector. |
| IXJ | iShares Global Healthcare ETF | Blackrock | Passive Equity | $4,013,865,000 | 1.28% | 0.40% | $85.19 | 3.93% | Seeks to track the investment results of an index composed of global equities in the healthcare sector. |
| IYH | iShares U.S. Healthcare ETF | Blackrock | Passive Equity | $3,032,150,000 | 1.19% | 0.39% | $280.77 | 4.13% | Seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. |
| LABD | Direxion Daily S&P Biotech Bear 3x Shares | Direxion | Passive Equity | $53,515,411 | 3.26% | 0.96% | $16.76 | -36.62% | Seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives. |
| LABU | Direxion Daily S&P Biotech Bull 3x Shares | Direxion | Passive Equity | $1,059,288,720 | 0.05% | 0.96% | $4.84 | 41.89% | Seeks to replicate 300% of the daily performance of its benchmark, the S&P Biotechnology Select Industry Index. |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | Invesco | Passive Equity | $233,023,050 | 0.02% | 0.59% | $60.85 | 9.66% | Based on the Dynamic Biotech & Genome Intellidex℠ Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X Shares | Direxion | Passive Equity | $10,637,506 | 2.34% | 0.97% | $9.28 | 7.68% | Seek daily investment results, before fees and expenses, of 300% of the performance of the S&P Pharmaceuticals Select Industry Index. There is no guarantee the fund will meet its stated investment objective. |
| PINK | Simplify Health Care ETF | Simplify | Fixed Income | $50,933,625 | 0.76% | 0.50% | $26.09 | 3.69% | Seeks long term capital appreciation by providing investors with multi-cap exposure to groundbreaking and innovative companies in biotech, medtech, gene therapy, and other fast growing health care related sectors. |
| PJP | Invesco Dynamic Pharmaceuticals ETF | Invesco | Passive Equity | $252,006,700 | 1.04% | 0.58% | $77.81 | 1.94% | The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index |
| PPH | VanEck Pharmaceutical ETF | VanEck | Passive Equity | $388,730,223 | 2.05% | 0.36% | $82.13 | 3.35% | VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR). |
| PSCH | Invesco S&P SmallCap Health Care ETF | Invesco | Passive Equity | $211,411,900 | 0.00% | 0.29% | $40.95 | 8.27% | Based on the S&P SmallCap 600 Capped Health Care Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. |
| PTH | Invesco DWA Healthcare Momentum ETF | Invesco | Passive Equity | $124,415,200 | 0.00% | 0.60% | $36.15 | 10.51% | Based on the Dorsey Wright Healthcare Technical Leaders Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. |
| RXD | ProShares UltraShort Health Care | ProShares | Passive Equity | $2,063,130 | 2.57% | 0.95% | $12.45 | -7.03% | Seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Dow Jones U.S. Health CareSM Index. |
| RXL | ProShares Ultra Health Care | ProShares | Passive Equity | $77,722,372 | 0.25% | 0.95% | $88.73 | 7.43% | Seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Health Care Index. |
| SBIO | ALPS Medical Breakthroughs ETF | SS&C | Passive Equity | $85,972,333 | 0.00% | 0.50% | $29.48 | 7.97% | Seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI). |
| VHT | Vanguard Health Care | Vanguard | Passive Equity | $16,277,259,893 | 1.44% | 0.10% | $244.27 | 4.50% | Seeks to track the performance of a benchmark index that measures the investment return of stocks in the health care sector. |
| XHE | SPDR S&P Health Care Equipment ETF | State Street Global X Advisors | Passive Equity | $314,465,900 | 0.01% | 0.35% | $85.27 | 10.29% | Seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of S&P Health Care Equipment Select Industry Index (the “Index”). |
| XHS | SPDR S&P Health Care Services ETF | State Street Global X Advisors | Passive Equity | $90,909,210 | 0.25% | 0.35% | $88.61 | 8.90% | Seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of S&P Health Care Services Select Industry Index (the “Index”). |
| XLV | Health Care Select Sector SPDR Fund | State Street Global Advisors | Passive Equity | $37,238,020,100 | 1.60% | 0.10% | 3.98% | The companies included in each Select Sector Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor’s 500 Composite Stock Index (“S&P 500”). | |
| XPH | SPDR S&P Pharmaceuticals ETF | State Street Global X Advisors | Passive Equity | $188,050,000 | 1.46% | 0.35% | $43.26 | 3.18% | Seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the “Index”) |
| HART | IQ Healthy Hearts ETF | New York Life | Passive Equity | $8,446,740 | 1.25% | 0.45% | $28.13 | 4.76% | The Fund seeks investment results that correspond to the performance of the IQ Candriam Healthy Hearts Index, which provides exposure to equity securities of companies that are making a positive contribution to global health-related goals . |
| HELX | Franklin Genomic Advancements E | Franklin | Active Equity | $11,248,240 | 0.00% | 0.50% | $30.14 | 7.45% | The Franklin Genomic Advancements ETF (HELX) is an actively managed fund that invests in companies that stand to benefit from advancements in genomic-based research techniques and technologies. |
| MEDI | Harbor Health Care ETF | Harbor | Active Equity | $4,657,000 | 0.00% | 0.80% | $22.19 | 7.65% | MEDI seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally. |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | First Trust | Active Equity | $5,761,429 | 0.00% | 0.65% | $15.63 | 13.32% | EKG tracks a market cap-weighted index of globally-listed companies engaged in digital health technologies. |
| XDNA | Kelly CRISPR & Gene Editing Technology ETF | Kelly Intelligence LLC | Passive Equity | $0 | 0.00% | 0.78% | $8.20 | 0.00% | Seeks to provide total return by investing in a passively managed, concentrated portfolio of companies that engage in CRISPR & gene editing technology activities. |
| GDOC | Goldman Sachs Future Health Care Equity ETF | Goldman Sachs | Active Equity | $24,542,480 | 0.00% | 0.75% | $31.66 | 7.11% | GDOC is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. |
| FDHT | Fidelity Digital Health ETF | Fidelity | Active Equity | $8,813,050 | 0.31% | 0.39% | $4.59 | 11.12% | FDHT tracks a market-cap-weighted index of globally-listed companies involved in digital health technologies. |
| APXH | APEX HealthCare ETF | HSRT | Active Equity | $3,991,500 | 0.30% | 0.95% | -0.45% | seeks to provide investment results that correspond generally, before fees and expenses, to the performance of the MarketGrader Global Health Care Leaders Index. | |
| PSIL | AdvisorShares Psychedelics ETF | AdvisorShares | Active Equity | $5,985,000 | 0.25% | 1.00% | $1.64 | -8.90% | PSIL is actively managed to provide exposure to the emerging global psychedelics industry. |
| MDEV | First Trust Indxx Medical Devices ETF | First Trust | Active Equity | $2,821,238 | 0.00% | 0.70% | $19.24 | 9.47% | MDEV tracks an equal-weighted index that gives global exposure to the medical equipment industry. |
| WDNA | WisdomTree BioRevolution Fund | WisdomTree | Active Equity | $2,480,000 | 0.42% | 0.45% | $17.45 | 10.08% | The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index . |
| POTX | Global X Cannabis ETF | Mirae Asset Global Investments Co., Ltd. | Active Equity | $29,294,151 | 4.81% | 0.51% | $6.41 | 1.43% | Seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cannabis Index. |
| CHIH | Global X MSCI China Health Care ETF | Global X | Active Equity | $9,104,729 | 0.62% | 0.65% | $13.48 | 0.73% | CHIH tracks a market cap-weighted index of Chinese large- and mid-cap companies in the health care sector. The index includes A shares. |
| KMED | KraneShares Emerging Markets Healthcare Index ETF | CICC | Active Equity | $1,880,920 | 0.24% | 0.79% | $19.67 | -5.64% | KMED seeks to provide investment results that, before fees and expenses, track the performance of the Solactive Emerging Markets Healthcare Index. |
| IEHS | iShares Evolved U.S. Healthcare Staples ETF | Blackrock | N/A | $35,188,640 | 0.79% | 0.18% | 4.43% | This ETF is no longer active. | |
| IEIH | iShares Evolved U.S. Innovative Healthcare ETF | Blackrock | N/A | $35,841,540 | 2.52% | 0.18% | 2.52% | This ETF is no longer active. | |
| KURE | KraneShares MSCI All China Health Care Index ETF | CICC | Active Equity | $63,557,220 | 0.06% | 0.65% | $17.25 | 2.09% | KURE tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. |
| VMOT | Alpha Architect Value Momentum Trend ETF | Alpha Architect | Active Equity | $38,214,000 | 2.35% | 2.55% | $22.39 | 5.46% | VMOT is an active, equal-risk-weighted portfolio of value- and momentum-oriented ETFs. The fund can fully hedge its equity exposure in down-trending markets. |
| HCRF | iShares Edge MSCI Multifactor Healthcare ETF | Blackrock | N/A | This ETF is no longer active | |||||
| XBI | SPDR S&P Biotech ETF | State Street Global Advisors | Active Equity | $6,341,588,400 | 0.00% | 0.35% | 14.02% | Seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select IndustryTM Index (the “Index”) | |
| CNCR | Range Cancer Therapeutics | Exchange Traded Concepts | Passive Equity | $11,668,814 | 0.00% | 0.79% | $12.09 | 11.86% | The Fund seeks to track the total return performance of the Range Cancer Therapeutics Index. |
| RSPH | Invesco S&P 500 Equal Weight Health Care | Invesco | Passive Equity | $906,843,000 | 3.73% | 0.40% | 7.11% | The Invesco S&P 500 Equal Weight Health Care ETF (Fund) is based on the S&P 500 Equal Weight Health Care Index (Index). |